Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...
The virus that causes COVID-19 has been very good at mutating to keep infecting people—so good that most antibody treatments ...
How is HKU5-CoV-2 similar to SARS-CoV-2? The discovery of HKU5-CoV-2 is concerning ... 10 point-explainer The research team, comprising experts from the Guangzhou Laboratory, Guangzhou Academy of ...
Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...
News-Medical.Net on MSN3d
Breakthrough peptide inhibitor effective against multiple SARS-CoV-2 variantsSARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.
A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the ...
Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...
Five years after the World Health Organization declared a global pandemic, there has been progress — and backsliding in the ...
Today in BMC Medicine, researchers in Catalonia, Spain, estimate that 23% of adult COVID-19 survivors develop long COVID, ...
8don MSN
Researchers have uncovered changes in the cellular response throughout lung damage caused by SARS-CoV-2—the virus behind ...
SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback